Skip to content

Evaluation of efficacy and safety of a topical polyherbal Unani formulation in Acne Vulgaris.

Evaluation of efficacy and safety of a topical Unani formulation in Buthu?r Labaniyya (Acne Vulgaris). - NIL

Status
Active, not recruiting
Phases
Phase 2
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2024/02/063169
Enrollment
44
Registered
2024-02-26
Start date
Unknown
Completion date
Unknown
Last updated
2024-03-04

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: L700- Acne vulgaris

Interventions

Intervention1: ?il ?’ (Thin paste) consists of fine powder of Irsa (Root of Iris ensata), Post-e-Siras (Bark of Albizia lebbeck), and Barg-e-Neem (Leaves of Azadirachta indica) in equal proportion, mi

Sponsors

Hakim Syed Ziaul Hasan Government Unani Medical College and Hospital
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: 1) Patients of either sex. 2) Patients of 13 to 40 years of age. 3) Mild to moderate acne as defined by the Global Acne Grading System (GAGS) scale. 4) Patients willing to sign the informed consent form.

Exclusion criteria

Exclusion criteria: 1) Patients suffering from any skin disease like vitiligo, psoriasis, eczema, etc. 2) Immunocompromised condition. 3) Any active psychiatric illness. 4) Pregnant and lactating women. 5) Patients with any systemic illness such as the known case of DM, HTN, etc. which might interfere with the follow-up and assessment during our study.

Design outcomes

Primary

MeasureTime frame
Change in Global Acne Grading System Scale (GAGS) of Acne vulgaris, from baseline to end of treatment.Timepoint: Baseline,2nd week,4th week,6th week

Secondary

MeasureTime frame
DLQI (Dermatology Life Quality Index)Timepoint: Baseline and 6th week

Countries

India

Contacts

Public ContactDr Atoofa

Hakim Syed Ziaul Hasan Government Unani Medical College and Hospital

dilshadali28@gmail.com9827140209

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026